UnitedHealth Group Management

Management Kriterienprüfungen 3/4

UnitedHealth Group's CEO ist Andrew Witty , ernannt in Feb 2021, hat eine Amtszeit von 3.33 Jahren. Die jährliche Gesamtvergütung beträgt $23.53M , bestehend aus 6.4% Gehalt und 93.6% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.011% der Aktien des Unternehmens, im Wert von MX$872.91M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 2.8 Jahre bzw. 5.8 Jahre.

Wichtige Informationen

Andrew Witty

Geschäftsführender

US$23.5m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	6.4%
Amtszeit als Geschäftsführer	3.3yrs
Eigentum des Geschäftsführers	0.01%
Durchschnittliche Amtszeit des Managements	2.8yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	5.8yrs

Jüngste Management Updates

Recent updates

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Andrew Witty im Vergleich zu den Einnahmen von UnitedHealth Group verändert?
Datum	Gesamtvergütung	Gehalt	Unternehmensgewinne
Mar 31 2024	n/a	n/a	US$15b
Dec 31 2023	US$24m	US$2m	US$22b
Sep 30 2023	n/a	n/a	US$22b
Jun 30 2023	n/a	n/a	US$21b
Mar 31 2023	n/a	n/a	US$21b
Dec 31 2022	US$21m	US$2m	US$20b
Sep 30 2022	n/a	n/a	US$19b
Jun 30 2022	n/a	n/a	US$18b
Mar 31 2022	n/a	n/a	US$17b
Dec 31 2021	US$18m	US$1m	US$17b
Sep 30 2021	n/a	n/a	US$15b
Jun 30 2021	n/a	n/a	US$15b
Mar 31 2021	n/a	n/a	US$17b
Dec 31 2020	US$13m	US$419k	US$15b
Sep 30 2020	n/a	n/a	US$17b
Jun 30 2020	n/a	n/a	US$17b
Mar 31 2020	n/a	n/a	US$14b
Dec 31 2019	US$17m	US$1m	US$14b
Sep 30 2019	n/a	n/a	US$13b
Jun 30 2019	n/a	n/a	US$13b
Mar 31 2019	n/a	n/a	US$13b
Dec 31 2018	US$22m	US$613k	US$12b
Sep 30 2018	n/a	n/a	US$13b
Jun 30 2018	n/a	n/a	US$12b
Mar 31 2018	n/a	n/a	US$11b
Dec 31 2017	US$62k	n/a	US$11b

Vergütung im Vergleich zum Markt: AndrewDie Gesamtvergütung ($USD23.53M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt MX ($USD5.85M).

Entschädigung vs. Einkommen: AndrewDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.

Geschäftsführer

Andrew Witty (59 yo)

3.3yrs

Amtszeit

US$23,534,936

Vergütung

Sir Andrew Philip Witty has been the Chief Executive Officer and Non-Independent Director of UnitedHealth Group Incorporated since February 3, 2021 and served as its Group President since November 2019 unt...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Andrew Witty	CEO & Non-Independent Director	3.3yrs	US$23.53m	0.011% $ 862.5m
John Rex	President & CFO	8yrs	US$16.07m	0.019% $ 1.5b
Rupert Bondy	Senior Counsel & Executive VP of Governance	less than a year	US$6.42m	0.00042% $ 34.4m
Brian Thompson	Chief Executive Officer of UnitedHealthcare	no data	US$10.22m	0.0035% $ 290.0m
Thomas Roos	Senior VP & Chief Accounting Officer	8.8yrs	keine Daten	0.0035% $ 287.5m
Sandeep Dadlani	Executive VP and Chief Digital & Technology Officer	1.8yrs	keine Daten	keine Daten
Zachary Sopcak	Senior Vice President of Capital Markets Communications & Investor Relations	2.3yrs	keine Daten	keine Daten
Chris Zaetta	Executive VP	less than a year	keine Daten	0.00087% $ 71.3m
Jennifer Smoter	Senior VP & Chief Communications Officer	3.3yrs	keine Daten	keine Daten
James Barry	Director of Sales for Western Pennsylvania	no data	keine Daten	keine Daten
Terry Clark	Executive VP & Chief Marketing Officer	10.4yrs	keine Daten	keine Daten
Erin L. McSweeney	Executive VP & Chief People Officer	2.3yrs	keine Daten	0.0010% $ 82.7m

2.8yrs

Durchschnittliche Betriebszugehörigkeit

59yo

Durchschnittliches Alter

Erfahrenes Management: UNH *Das Führungsteam des Unternehmens gilt als erfahren (2.8 Jahre durchschnittliche Betriebszugehörigkeit).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Andrew Witty	CEO & Non-Independent Director	3.3yrs	US$23.53m	0.011% $ 862.5m
Stephen Hemsley	Non-Independent Non-Executive Chairman	24.3yrs	US$595.35k	0.12% $ 10.0b
Michele Hooper	Lead Independent Director	16.7yrs	US$441.52k	0.00037% $ 30.3m
Paul Garcia	Independent Director	2.6yrs	US$366.80k	0.00033% $ 27.0m
Timothy Flynn	Independent Director	7.4yrs	US$400.16k	0.00038% $ 31.1m
Frederick McNabb	Independent Director	6.3yrs	US$392.88k	0.00070% $ 57.3m
John Noseworthy	Independent Director	5.3yrs	US$391.05k	keine Daten
Valerie C. Rice	Independent Director	6.8yrs	US$391.05k	0.000040% $ 3.3m
Kristen Gil	Independent Director	1.5yrs	US$351.80k	0.000050% $ 4.1m
Charles Baker	Independent Director	less than a year	US$59.33k	keine Daten

5.8yrs

Durchschnittliche Betriebszugehörigkeit

67.5yo

Durchschnittliches Alter

Erfahrener Vorstand: UNH *Die Vorstandsmitglieder gelten als erfahren (5.8 Jahre durchschnittliche Amtszeit).

UnitedHealth Group Management

Management Kriterienprüfungen 3/4

Wichtige Informationen

Jüngste Management Updates

UnitedHealth Group Incorporated Announces Management Changes, Effective June 4, 2024

UnitedHealth Group Incorporated, Annual General Meeting, Jun 03, 2024

Executive VP & Chief People Officer recently sold Mex$10m worth of stock

Senior VP & Chief Accounting Officer recently sold Mex$7.7m worth of stock

Executive VP & CEO of UnitedHealthcare recently sold Mex$209m worth of stock

Unitedhealth Group Incorporated Announces Retirement of Dirk McMahon as President and Chief Operating Officer, Effective April 1, 2024

Recent updates

UnitedHealth Group Incorporated to Report Q2, 2024 Results on Jul 16, 2024

First quarter dividend of US$2.10 announced

UnitedHealth Group Announces Cash Dividend, Payable on June 25, 2024

New minor risk - Share price stability

UnitedHealth Group Incorporated Announces Management Changes, Effective June 4, 2024

First quarter 2024 earnings released: US$1.53 loss per share (vs US$6.01 profit in 1Q 2023)

UnitedHealth Group Incorporated, Annual General Meeting, Jun 03, 2024

New major risk - Financial position

First quarter 2024 earnings released: US$1.53 loss per share (vs US$6.01 profit in 1Q 2023)

UnitedHealth Group Incorporated Provides Earnings Guidance for the Full Year 2024

UnitedHealth Group Incorporated to Report Q1, 2024 Results on Apr 16, 2024

Court Substantially Denies United Healthcare’s Motion for Summary Judgment in ERISA Class Action: Case Moves to Trial

Executive VP & Chief People Officer recently sold Mex$10m worth of stock

Fourth quarter dividend of US$1.88 announced

Full year 2023 earnings released: EPS: US$24.12 (vs US$21.47 in FY 2022)

Senior VP & Chief Accounting Officer recently sold Mex$7.7m worth of stock

UnitedHealth Group Announces Quarterly Dividend, Payable on March 19, 2024

Executive VP & CEO of UnitedHealthcare recently sold Mex$209m worth of stock

Unitedhealth Group Incorporated Announces Retirement of Dirk McMahon as President and Chief Operating Officer, Effective April 1, 2024

Full year 2023 earnings released: EPS: US$23.86 (vs US$21.47 in FY 2022)

UnitedHealth Group Incorporated to Report Q4, 2023 Results on Jan 12, 2024

Unitedhealth Group Incorporated Provides Earnings Guidance for the Year 2023 and 2024

Upcoming dividend of US$1.88 per share at 1.4% yield

UnitedHealth Group Incorporated Announces Cash Dividend, Payable on December 12, 2023

UnitedHealth Group Incorporated Appoints Charlie Baker to Board of Directors

Unitedhealth Group Incorporated Announces Earnings Guidance for the Full Year 2023

Third quarter 2023 earnings released: EPS: US$6.24 (vs US$5.63 in 3Q 2022)

Now 20% undervalued

UnitedHealth Group Incorporated to Report Q3, 2023 Results on Oct 13, 2023

Upcoming dividend of US$1.88 per share at 1.6% yield

Unitedhealth Group Board Authorizes Payment of Quarterly Dividend, Payable on September 19, 2023

CEO & Non-Independent Director recently sold Mex$34m worth of stock

UnitedHealth Group Incorporated Provides Earnings Guidance for the Full Year 2023

Second quarter 2023 earnings released: EPS: US$5.82 (vs US$5.41 in 2Q 2022)

Now 20% undervalued after recent price drop

UnitedHealth Group Incorporated to Report Q2, 2023 Results on Jul 14, 2023

Unitedhealth Group Incorporated Announces Quarterly Cash Dividend, Payable on June 27, 2023

Now 20% undervalued after recent price drop

Mercy Investment Files an Exempt Solicitation and Urge Vote For its Proposal

Executive VP & Chief People Office recently sold Mex$24m worth of stock

First quarter 2023 earnings released: EPS: US$5.95 (vs US$5.34 in 1Q 2022)

Now 21% undervalued after recent price drop

Full year 2022 earnings released: EPS: US$21.47 (vs US$18.33 in FY 2021)

Now 20% undervalued after recent price drop

Full year 2022 earnings released: EPS: US$21.18 (vs US$18.33 in FY 2021)

UnitedHealth Group Incorporated to Report Q4, 2022 Results on Jan 13, 2023

Kristen Gil Joins Unitedhealth Group Incorporated Board of Directors

Executive VP & Chief People Office recently sold Mex$4.8m worth of stock

Upcoming dividend of US$1.65 per share

UnitedHealth Group Incorporated Authorizes Payment of Quarterly Dividend, Payable on December 13, 2022

Third quarter 2022 earnings released: EPS: US$5.55 (vs US$4.33 in 3Q 2021)

Unitedhealth Group Incorporated Increases Earnings Guidance for the Full Year 2022

Now 23% undervalued after recent price drop

Now 20% undervalued

Judge Denies U.S. Bid to Stop UnitedHealth Plan to Buy Change

UnitedHealth Group Incorporated to Report Q3, 2022 Results on Oct 14, 2022

Upcoming dividend of US$1.65 per share

Senior VP & Chief Accounting Officer recently sold Mex$5.0m worth of stock

Amazon Reportedly Among Bidders for Signify Health

President & COO recently sold Mex$160m worth of stock

UnitedHealth Group Announces Quarterly Dividend, Payable on September 20, 2022

CEO & Director recently sold Mex$123m worth of stock

Second quarter 2022 earnings released: EPS: US$5.34 (vs US$4.52 in 2Q 2021)

Unitedhealth Group Incorporated Revises Earnings Guidance for the Full Year of 2022

Now 21% undervalued after recent price drop

Executive VP & Chief People Office recently sold Mex$13m worth of stock

Now 21% undervalued after recent price drop

UnitedHealth Group Incorporated Approves Payment of a Cash Dividend, Payable on June 28, 2022

Independent Director recently bought Mex$888k worth of stock